Overview / Abstract: |
Two new drugs in novel classes were approved recently for IOP reduction in eyes with ocular hypertension or open-angle glaucoma. View this webinar, hosted by two glaucoma experts, to learn more about these new treatments, plus therapeutics pending approval by the FDA. A case series is also included in this presentation. This webcast with two thought leaders discusses these novel classes. |
Expiration |
Jul 31, 2022 |
Discipline(s) |
Optometry / Ophthalmology CE |
Format |
Webinar / Webcast / Video |
Credits / Hours |
1 |
Accreditation |
COPE, |
Presenters / Authors / Faculty |
JONATHAN S. MYERS, MD; DOUGLAS J. RHEE, MD |
Sponsors / Supporters / Grant Providers |
This Activity is supported by an unrestricted educational grant from Aerie. |
Keywords / Search Terms |
Evolve Medical Education LLC ophtalmology, optometry, glaucoma ,ocular hypertension, IOP Free CE CME |